James A. Geraghty, Director at GTC BIOTHERAPEUTICS INC (GTCB), bought 10,000 shares at $0.87 ($9K) on 2007-12-14, disclosed to the SEC on 2007-12-17.
Open-market purchase of $9k GTCB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.87 | 1,400 | $1K | 14.0% |
| 2 | $0.87 | 1,500 | $1K | 15.0% |
| 3 | $0.87 | 1,700 | $1K | 17.0% |
| 4 | $0.87 | 5,400 | $5K | 54.0% |
| Total | $0.87 avg | 10,000 | $9K | 100% |
| Filing → |
| VYGR | BUY | 2018-08-21 | $110K | — | Filing → |
| IDRA | BUY | 2018-08-08 | $56K | — | Filing → |
| PIRS | BUY | 2018-05-16 | $58K | — | Filing → |